Arbutus Biopharma Corporation ABUS Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's deferred tax assets and other non-current assets?
- Arbutus Biopharma Corporation (ABUS) reported deferred tax assets and other non-current assets of $131K in Q1 2026.
- How has Arbutus Biopharma Corporation's deferred tax assets and other non-current assets changed year-over-year?
- Arbutus Biopharma Corporation's deferred tax assets and other non-current assets increased by 285.3% year-over-year, from $34K to $131K.
- What is the long-term trend for Arbutus Biopharma Corporation's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's deferred tax assets and other non-current assets has grown at a 24.2% compound annual growth rate (CAGR), from $44K to $130K.